SERUM ADALIMUMAB TROUGH LEVELS REQUIRED FOR ENDOSCOPIC MUCOSAL HEALING DURING MAINTENANCE THERAPY OF CROHN'S DISEASE

被引：1
|
作者：
Imaeda, Hirotsugu
Nishino, Kyohei
Ohno, Masashi
Nishida, Atsushi
Sugimoto, Mitsushige
Andoh, Akira
机构：
来源：
GASTROENTEROLOGY | 2017年 / 152卷 / 05期
关键词：
D O I：
10.1016/S0016-5085(17)31553-6
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Sa1918
引用
收藏
页码：S393 / S393
页数：1
相关论文
共 50 条
  • [11] Association Between Serum Infliximab Trough Concentrations During Maintenance Therapy and Biochemical, Endoscopic, and Histologic Remission in Crohn's Disease
    Papamichael, Konstantinos
    Rakowsky, Shana
    Rivera, Claudio
    Cheifetz, Adam S.
    Osterman, Mark T.
    INFLAMMATORY BOWEL DISEASES, 2018, 24 (10) : 2266 - 2271
  • [12] Improved mucosal healing during scheduled adalimumab maintenance therapy in patients with Crohn's disease initiated following surgical resection of active lesions
    Yamada, A.
    Iwashita, H.
    Sasaki, T.
    Katsumata, M.
    Miyamura, M.
    Kikuchi, H.
    Arai, T.
    Iwasa, R.
    Furukawa, R.
    Sono, K.
    Osamura, A.
    Nakamura, K.
    Aoki, H.
    Yoshimatsu, Y.
    Tsuda, Y.
    Takeuchi, K.
    Takada, N.
    Suzuki, Y.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S358 - S359
  • [13] Endoscopic and Mucosal Healing in Crohn's Disease with Azathioprine
    Nadir, Isilay
    Kafadar, Mehmet Tolga
    Kasapoglu, Benan
    JOURNAL OF CLINICAL AND ANALYTICAL MEDICINE, 2016, 7
  • [14] ADALIMUMAB TROUGH LEVELS AND ANTI-ADALIMUMAB ANTIBODIES CORRELATE WITH CLINICAL AND ENDOSCOPIC ACTIVITY IN CROHN'S DISEASE PATIENTS
    Pellegatta, G.
    Lo Pumo, S.
    Bodini, G.
    Baldissarro, I.
    Giannini, E. G. B.
    Savarino, V.
    Jain, A.
    Savarino, E.
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : E135 - E135
  • [15] Infliximab trough levels are associated with transmural healing during maintenance treatment in pediatric Crohn's disease patients
    Kang, Ben
    Choi, So Yoon
    Choi, Young Ok
    Kim, Mi Jin
    Jeon, Tae Yeon
    Choe, Yon Ho
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2018, 33 : 64 - 65
  • [16] Higher Adalimumab Drug Levels During Maintenance Therapy for Crohn's Disease Are Associated With Biologic Remission
    Plevris, Nikolas
    Lyons, Mathew
    Jenkinson, Philip W.
    Chuah, Cher S.
    Merchant, Lynne M.
    Pattenden, Rebecca J.
    Watson, Eleanor F.
    Ho, Gwo-Tzer
    Noble, Colin L.
    Shand, Alan G.
    Din, Shahida
    Arnott, Ian D.
    Jones, Gareth R.
    Lees, Charlie W.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 (06) : 1036 - 1043
  • [17] The effect of adalimumab for induction of endoscopic healing and normalization of mucosal cytokine gene expression in Crohn's disease
    Rismo, Renathe
    Olsen, Trine
    Ciu, Guanglin
    Paulssen, Eyvind J.
    Christiansen, Ingrid
    Florholmen, Jon
    Goll, Rasmus
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2012, 47 (10) : 1200 - 1210
  • [18] Identification of Target Golimumab Levels in Maintenance Therapy of Crohn's Disease and Ulcerative Colitis Associated With Mucosal Healing
    Boland, Karen
    Greener, Tomer
    Kabakchiev, Boyko
    Stempak, Joanne
    Tessolini, Jenna
    Li, Rachelle
    Soriano, Joelle
    Croitoru, Kenneth
    Nguyen, Geoffrey
    Steinhart, A. Hillary
    Weizman, Adam, V
    Silverberg, Mark S.
    INFLAMMATORY BOWEL DISEASES, 2020, 26 (05) : 766 - 773
  • [19] Adalimumab Trough Levels in a Prospective Cohort of Crohn's Disease Patients
    van der Woude, Christien J.
    Deuring, J. Jasper
    West, Rachel
    Zelinkova, Zuzana
    Peppelenbosch, Maikel P.
    GASTROENTEROLOGY, 2013, 144 (05) : S567 - S567
  • [20] Adalimumab trough levels predict Crohn's disease clinical course
    Ribaldone, Davide Giuseppe
    Manetta, Tilde
    Mengozzi, Giulio
    Saracco, Giorgio Maria
    Pellicano, Rinaldo
    Astegiano, Marco
    DIGESTIVE AND LIVER DISEASE, 2018, 50 (02) : 204 - 206
12345